The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
about
Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis.Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens.Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinomaTumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy.Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomyThe prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy.Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy.Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.Prediction of pathological outcomes for a single microfocal (≤3 mm) Gleason 6 prostate cancer detected via contemporary multicore (≥12) biopsy in men with prostate-specific antigen ≤10 ng/mL.Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer.Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer.High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin.
P2860
Q33983603-4184CB36-7000-42B9-BB96-B16A61ED2C57Q35009882-6840FA9A-C672-4742-A0F1-E43CA16ACE62Q35870404-4247B9E2-6A15-4833-A8AF-FC8571B01F45Q36104473-978F0E4F-F310-44FD-9A3E-2496C1F22BD0Q36530243-3711D72D-E98F-4684-9B10-6451384D2BD0Q37085214-0348C5A9-3600-4CCC-B310-5C57CEBBD5C9Q37676133-F8F9E383-27AC-414B-AB8E-C7BF18CFB112Q38026501-ED1F4257-5047-42D9-B921-7E42038FB755Q43425184-83E4323A-72B8-43B4-AAEC-FD4682ECD461Q46356642-5D1CDD3C-E31B-468F-8018-D903628DF5C9Q46873257-B8553366-923B-4F91-8C3C-77906351BCD7Q48674916-3E624B83-9396-497D-BE83-9D6CA6DEEBF6Q49919227-EEFA028B-B4F3-47B2-8415-113660312B19Q54566679-B53CC441-3EFB-47A6-A787-FD806441557C
P2860
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The independent value of tumou ...... clinically localized disease.
@ast
The independent value of tumou ...... clinically localized disease.
@en
type
label
The independent value of tumou ...... clinically localized disease.
@ast
The independent value of tumou ...... clinically localized disease.
@en
prefLabel
The independent value of tumou ...... clinically localized disease.
@ast
The independent value of tumou ...... clinically localized disease.
@en
P2860
P1433
P1476
The independent value of tumou ...... clinically localized disease.
@en
P2093
Peter R Carroll
Sima P Porten
P2860
P304
P356
10.1111/J.1464-410X.2009.08774.X
P577
2009-08-13T00:00:00Z